/stocks — the workspaceLOADING
Caribou Biosciences, Inc. (CRBU) is a biological products, (no diagnostic substances) company. Piotroski F-Score 2/7. Next earnings projected around 2026-08-11 from CRBU's year-over-year reporting pattern (not yet company-confirmed). Fundamentals from SEC filings; prices are end-of-day.
EOD daily bars · delayed, not real-time · data: DatabentoCharting by TradingView Lightweight Charts™
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
FY ending 2025-12-31 vs 2024-12-31. original 1968 formula; calibrated on manufacturers, read financials/REITs with care
A plain-English read on CRBU plus an auto-SWOT — built from CRBU's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate CRBU using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
| Kelly Timothy PChief Technology Officer | SELL | $12K | view → |
| Albertson Tina M.Chief Medical Officer | SELL | $2K | view → |
| Khan Ruhi AhmadChief Business Officer | SELL | $14K | view → |
| MCCLUNG BARBARA GChief Legal Officer | SELL | $14K | view → |
| Kelly Timothy PChief Technology Officer | SELL | $6K | view → |
Projected from CRBU's own SEC 8-K filing history — the year-over-year reporting pattern (~50% land the exact day, ~90% within a week). No analyst estimates, no scraped calendars, nothing invented. It upgrades to a confirmed date + time the moment CRBU files its announcement.
CRBU has sold off after 5 of its last 8 earnings reports.
Large earnings reactions have been common.
CRBU has traded lower after most recent earnings releases.
A more typical earnings reaction has been approximately ±7.9%.
Realized close-to-close history only — no options-implied move, no analyst estimates.
| Reported | Close-to-close |
|---|---|
| 2026-05-07 | -0.5% |
| 2026-03-05 | +1.1% |
| 2025-11-03 | -10.3% |
| 2025-08-12 | +14.0% |
| 2025-04-24 | -8.1% |
| 2025-03-10 | -7.8% |
| 2024-11-06 |
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
| +8.6% |
| 2024-08-06 | -2.8% |